Experience

Davis Polk is advising One Madison Corporation on its acquisition of Ranpak Corporation from affiliates of Rhône Capital. The transaction will introduce Ranpak as a publicly listed company…

Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of $250 million 4.375% notes due 2024 (to be consolidated and form a single series with the $600…

Davis Polk advised the initial purchaser in connection with a $150 million Regulation S high-yield offering by KWG Group Holding Limited of its 9.85% senior notes due 2020 (to be…

Davis Polk advised the initial purchasers in connection with a $370 million Regulation S only offering by Logan Property Holdings Company Limited of its 8.75% senior notes due 2020…

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame Intermédica and by Bain Capital, the controlling shareholder of Notre Dame…

Davis Polk advised the joint lead managers in connection with the drawdown by the issuer of its $300 million 4.250% notes due 2021. CITICS is a full-service investment bank in China…

Davis Polk is advising Nutrisystem, Inc. on its $1.4 billion acquisition by Tivity Health, Inc. The transaction, which is expected to close in the first quarter of 2019, is subject to…

Davis Polk advised the underwriters on the SEC-registered initial public offering by MOGU Inc. of 4,750,000 American Depositary Shares, each representing 25 Class A ordinary shares,…

Davis Polk advised the administrative agent, the sole lead arranger and the sole bookrunner, in connection with the amendment and restatement of a $1 billion senior unsecured revolving…

Davis Polk is advising Mereo BioPharma Group plc on its combination with OncoMed Pharmaceuticals, Inc. The transaction, which is subject to customary closing conditions and the approval of…